Cargando…
How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells
Vaccination, being able to prevent millions of cases of infectious diseases around the world every year, is the most effective medical intervention ever introduced. However, immunosenescence makes vaccines less effective in providing protection to older people. Although most studies explain that thi...
Autores principales: | Aiello, Anna, Ligotti, Mattia Emanuela, Garnica, Maider, Accardi, Giulia, Calabrò, Anna, Pojero, Fanny, Arasanz, Hugo, Bocanegra, Ana, Blanco, Ester, Chocarro, Luisa, Echaide, Miriam, Fernandez-Rubio, Leticia, Ramos, Pablo, Piñeiro-Hermida, Sergio, Kochan, Grazyna, Zareian, Nahid, Farzaneh, Farzin, Escors, David, Caruso, Calogero, Candore, Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456428/ https://www.ncbi.nlm.nih.gov/pubmed/36077278 http://dx.doi.org/10.3390/ijms23179880 |
Ejemplares similares
-
How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells
por: Garnica, Maider, et al.
Publicado: (2022) -
Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention
por: Aiello, Anna, et al.
Publicado: (2019) -
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
por: Ligotti, Mattia Emanuela, et al.
Publicado: (2021) -
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors
por: Blanco, Ester, et al.
Publicado: (2023) -
Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor
por: Chocarro, Luisa, et al.
Publicado: (2022)